These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. Goodnough LT; Verbrugge D; Marcus RE; Goldberg V J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386 [TBL] [Abstract][Full Text] [Related]
6. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. Goodnough LT; Brittenham GM J Lab Clin Med; 1990 Jan; 115(1):28-35. PubMed ID: 2299254 [TBL] [Abstract][Full Text] [Related]
7. Intravenous vs. oral iron supplementation during autologous blood donation. Gesemann M; Mielsch I; Gentner PR; Weigand H; Scheiermann N Beitr Infusionsther Transfusionsmed; 1996; 33():180-3. PubMed ID: 8865945 [TBL] [Abstract][Full Text] [Related]
8. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Bovy C; Baudoux E; Salmon JP; Beguin Y Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592 [TBL] [Abstract][Full Text] [Related]
9. [Changes in hematological indices, iron levels and marrow erythroids through autologous blood donation before cardiac surgery--predonation with versus without recombinant human erythropoietin]. Shinonaga M Nihon Kyobu Geka Gakkai Zasshi; 1995 Apr; 43(4):479-87. PubMed ID: 7608597 [TBL] [Abstract][Full Text] [Related]
10. [Recombinant erythropoietin in autologous blood donation]. von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712 [TBL] [Abstract][Full Text] [Related]
11. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. Goodnough LT; Price TH; Rudnick S J Lab Clin Med; 1991 Sep; 118(3):289-96. PubMed ID: 1919301 [TBL] [Abstract][Full Text] [Related]
12. [Recombinant human erythropoietin (KRN5702) therapy for autologous blood transfusion in patients with rheumatoid arthritis undergoing joint replacement surgery--a multicenter phase II clinical trial]. Saikawa I; Sugioka Y; Hotokebuchi T; Tsutsui H; Inaba S; Takagishi K; Iwata H; Ogawa R; Kondo M; Ogata K Ryumachi; 1994 Jun; 34(3):583-93. PubMed ID: 8052924 [TBL] [Abstract][Full Text] [Related]
20. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery]. Szöcs M; Donauer E; Simon J; Gál G; Kovács G Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]